CST7 has been previously reported to increase in Alzheimer’s disease (AD) and as a cytotoxic marker for cytotoxic CD8 T cells in colorectal cancer with a hypomethylation status. Here, CST7 is linked to early-onset autosomal dominant Alzheimer disease.